Clinical trial: Effects of tegaserod on gastric motor and sensory function in patients with functional dyspepsia

Alimentary Pharmacology and Therapeutics

Volumn 26, Issue 10, 2007, Pages 1399-1407

  Thumshirn, M ^a,c   Fruehauf, H ^a   Stutz, B ^a   Tougas, G ^b   Salter, J ^b   Fried, M ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b NOVARTIS PHARMA AG   (Switzerland)

^c St Claraspital AG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

TEGASEROD;

ADULT; ANALYTIC METHOD; ARTICLE; BAROSTAT; CLINICAL ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIARRHEA; DIET RESTRICTION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DYSPEPSIA; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; LOOSE FECES; MALE; MIGRAINE; POSTPRANDIAL STATE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SENSORY SYSTEM; STOMACH MOTILITY; VOLUNTEER;

ADULT; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; DYSPEPSIA; FEMALE; GASTRIC EMPTYING; GASTROINTESTINAL MOTILITY; HUMANS; INDOLES; MALE; PATIENT COMPLIANCE; SEROTONIN AGONISTS; TREATMENT OUTCOME;

EID: 35748942244     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2007.03521.x     Document Type: Article

References (25)

1. Talley NJ, Heading RC, Koch KL, Malagelada J-R, Tytgat GJN. Functional gastrointestinal disorders. Gut 1999 45 (Suppl. II 37 42.
2. Talley NJ, Silverstein MD, Agreus L, et al. AGA Technical review: Evaluation of Dyspepsia. Gastroenterology 1998 114 : 582 95.
3. Stanghellini V, Tosetti C, Paternico A, et al. Risk indicators of delayed gastric emptying of solids in patients with functional dyspepsia. Gastroenterology 1996 110 : 1036 42.
4. Tack J, Coulie B, Caenepeel P, Janssens J. Role of impaired gastric accommodation to a meal in functional dyspepsia. Gastroenterology 1998 115 : 1346 52.
5. Thumshirn M, Camilleri M, Saslow SB, et al. Gastric accommodation in non-ulcer dyspepsia and the roles of Helicobacter pylori infection and vagal function. Gut 1999 44 : 55 64.
6. De Ponti F. Functional gut disorders: from motility to sensitivity disorders. A review of current and investigational drugs for their management. Pharmalcol Ther 1998 80 : 49 88.
7. Muller-Lissner SA, Fumagalli I, Bardhan KD, et al. Tegaserod, a 5-HT4 receptor partial agonist relieves symptoms in irritable bowel syndrome patients with abdominal pain, bloating and constipation. Aliment Pharmacol Ther 2001 15 : 1655 66.
8. Degen L, Matzinger D, Merz M, et al. Tegaserod, a 5-HT4 receptor partial agonist, accelerates gastric emptying and gastrointestinal transit in healthy male subjects. Aliment Pharmacol Ther 2001 15 : 1745 51.
9. Degen L, Studer D, Schroller S, Beglinger C. Effect of tegaserod on gut transit in male and female subjects. Neurogastroenterol Motil 2005 17 : 821 6.
10. Tack J, Bisschops R, Tougas G, Janssens J, Phillips T. Effect of tegaserod, a 5-HT4 receptor agonist, on sensory and motor function of the proximal stomach in functional dyspepsia. Gastroenterology 2005 128 (Suppl. 2 A-94.
11. Coelho AM, Fioramonti J, Buoeno L. Antinociceptive properties of HTF 919 (Tegaserod), a 5-HT4 receptor partial agonist, on colorectal distension in rat. Gastroenterology 2000 118 : A835.
12. Tack J, Janssens J, Salter J, Jaufferet S, Vandeplassche G. Influence of tegaserod on proximal gastric tone and on the perception of gastric distension. Aliment Pharmacol Ther 2003 18 : 1031 7.
13. Ropert A, Bizais Y, et al. Simultaneous assessment of liquid emptying and proximal gastric tone in humans. Gastroenterology 1993 105 : 667 74.
14. Azpiroz F. Vagally mediated gastric relaxation induced by intestinal nutrients in the dog. Am J Physiol 1986 251 : G727 35.
15. Feinle C, Read NW. CCK-A receptors modulate gastric sensory and motor responses to gastric distension and duodenal lipid. Gastroenterology 1996 110 : 1379 85.
16. Veldhuyzen van Zanten SJOV, Verlinden M, Talley NJ. Efficacy of cisapride and domperidone in functional dyspepsia: a metaanalysis. Am J Gastroenterol 2001 96 : 689 96.
17. Finney JS, Kinnersley N, Hughes M, et al. Meta-analysis of antisecretory and gastrokinetic compounds in functional dyspepsia. J Clin Gastroenterol 1998 26 : 312 20.
18. Tack J, Coulie B, Janssens J. The influence of cisapride on gastric tone and perception of gastric distension. Aliment Pharmacol Ther 1998 12 : 761 6.
19. Talley NJ, Geenen DJ, Hogan RB, et al. Failure of a motilin receptor agonist (ABT-229) to relieve symptoms of functional dyspepsia in patients with and without delayed gastric emptying: a randomized double-blind placebo-controlled trial. Aliment Pharmacol Ther 2000 14 : 1653 61.
20. Piessevaux H, Wilmer A, Coulie B, et al. Perception of changes in wall tension of the proximal stomach in humans. Gut 2001 49 : 203 8.
21. Tack J, Caenepeel P, Fischler B, et al. Symptoms associated with hypersensitivity to gastric distension in functional dyspepsia. Gastroenterology 2001 121 : 526 35.
22. Fried M, Feinle C. The role of fat and cholecystokinin in functional dyspepsia. Gut 2002 51 (Suppl. 54 7.
23. Feinle C, Otto B, D'Amato M, Fried M. Role of duodenal lipid and cholecystokinin A receptors in the pathophysiology of functional dyspepsia. Gut 2001 48 : 347 55.
24. Mertz H, Fullerton S, Naliboff B, et al. Symptoms and visceral perception in severe functional and organic dyspepsia. Gut 1998 42 : 814 22.
25. Tougas G, Luo D, Salter J, et al. Tegaserod improves gastric emptying in patients with gastroparesis and dyspeptic symptoms. Gastroenterology 2003 124 (Suppl. 1 A 54.